Interferential Current And Trapezius Myofascial Trigger Points

NCT ID: NCT05275634

Last Updated: 2023-05-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

68 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-06-01

Study Completion Date

2023-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To investigate the effect of different carrier frequencies of interferential current on pressure pain threshold, neck disability, cervical range of motion and upper trapezius muscle activity when applied on upper trapezius chronic myofascial trigger points: Randomized Controlled Trial

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Interferential current (IFC) is a medium frequency current derived from the interference of two symmetrical, but asynchronous alternating currents ranged from 1 to 10 KHz. The two main currents resulting in a single interference current with properties uniquely different from the two original currents.The lesser current of the two original currents is termed the carrier frequency and the interference current is called the beat frequency. A specific beat frequency can be obtained from several possible interference currents as long as the difference between the original currents is the same. For electro pain modulation, IFC is commonly used form of electrotherapy. It has the advantage of reducing the skin impedance, deeper penetration into tissues and is perceived as more comfortable.

Myofascial pain syndrome (MPS) is a common form of chronic musculoskeletal pain that widely spread and contributing to a significant financial burden and job- related disability. It represents the most common disorder in patients with nonspecific chronic neck pain.The main characteristics of MPS include the presence of myofascial trigger points (MTrPs) which are defined as hyperirritable nodule in a taut band of skeletal muscle fibers which is palpable and tender during physical examination. Trigger points (TrPs) are usually seen in the upper fiber of trapezius. TrPs can be clinically classified as either active or latent. Active TrPs was defined as: MTrPs that refer pain during activity and during rest without any pressure. They prevent full muscle lengthening and induce their weakness. Latent TrPs was defined as: MTrPs that is painful only when palpated. Evidence on the effect of IFC on pain modulation is not confirmed up till now. This might be attributed to multiple factors such as limited number of studies, inappropriate use of the parameters or using single carrier frequency (4 KHz) in majority of studies and the physiological effects of all our modalities are dose dependent. Dose depends on details of parameters including frequency. For IFC, the carrier frequency of the current has been suggested as an important parameter to achieve the most effective hypoalgesic response. However, there remains no evidence to support the selection of one carrier frequency over another. Few studies were conducted to examine the effect of different carrier frequencies by comparing their individual effects. Further researches are needed to prove which carrier frequency is more effective in treatment. Therefore, this study will be conducted to compare the effect of different carrier frequencies of the IFC in the management of upper trapezius chronic TrPs.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Upper Trapezius Trigger Points

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This trial has four groups; three experimental and one group control.
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors
Double (Participant, Outcomes Assessor)

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard treatment and interferential current with carrier frequency 2 KHz

Standard treatment and interferential current with carrier frequency 2 KHz will be received three times a week for four weeks.

Group Type EXPERIMENTAL

Stander treatment

Intervention Type OTHER

Standard treatment will be (active cervical range of motion exercises, myofascial release to upper trapezius muscle and postural advices at home).

Interferential current with carrier frequency 2 KHz

Intervention Type DEVICE

Interferential current treatment parameters will be as following; carrier frequency 2 KHz and beat frequency 15 Hz performed for 45 minutes per session.The intensity will be raised according to the subject's tolerance, remaining in the sensory level.

Standard treatment and interferential current with carrier frequency 4 KHz

Standard treatment and interferential current with carrier frequency 4 KHz will be received three times a week for four weeks.

Group Type EXPERIMENTAL

Stander treatment

Intervention Type OTHER

Standard treatment will be (active cervical range of motion exercises, myofascial release to upper trapezius muscle and postural advices at home).

Interferential current with carrier frequency 4 KHz

Intervention Type DEVICE

Interferential current treatment parameters will be as following; carrier frequency 4 KHz and beat frequency 15 Hz performed for 45 minutes per session.The intensity will be raised according to the subject's tolerance, remaining in the sensory level.

Standard treatment and interferential current with carrier frequency 8 KHz

Standard treatment and interferential current with carrier frequency 8 KHz will be received three times a week for four weeks.

Group Type EXPERIMENTAL

Stander treatment

Intervention Type OTHER

Standard treatment will be (active cervical range of motion exercises, myofascial release to upper trapezius muscle and postural advices at home).

Interferential current with carrier frequency 8 KHz

Intervention Type DEVICE

Interferential current treatment parameters will be as following; carrier frequency 8 KHz and beat frequency 15 Hz performed for 45 minutes per session.The intensity will be raised according to the subject's tolerance, remaining in the sensory level.

Standard treatment and placebo interferential current

Standard treatment and placebo interferential current will be received three times a week for four weeks.

Group Type PLACEBO_COMPARATOR

Stander treatment

Intervention Type OTHER

Standard treatment will be (active cervical range of motion exercises, myofascial release to upper trapezius muscle and postural advices at home).

placebo interferential current

Intervention Type DEVICE

Interferential current intensity will not be raised.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Stander treatment

Standard treatment will be (active cervical range of motion exercises, myofascial release to upper trapezius muscle and postural advices at home).

Intervention Type OTHER

Interferential current with carrier frequency 2 KHz

Interferential current treatment parameters will be as following; carrier frequency 2 KHz and beat frequency 15 Hz performed for 45 minutes per session.The intensity will be raised according to the subject's tolerance, remaining in the sensory level.

Intervention Type DEVICE

Interferential current with carrier frequency 4 KHz

Interferential current treatment parameters will be as following; carrier frequency 4 KHz and beat frequency 15 Hz performed for 45 minutes per session.The intensity will be raised according to the subject's tolerance, remaining in the sensory level.

Intervention Type DEVICE

Interferential current with carrier frequency 8 KHz

Interferential current treatment parameters will be as following; carrier frequency 8 KHz and beat frequency 15 Hz performed for 45 minutes per session.The intensity will be raised according to the subject's tolerance, remaining in the sensory level.

Intervention Type DEVICE

placebo interferential current

Interferential current intensity will not be raised.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Ages from18-29 years old with unilateral chronic myofascial trigger points in upper trapezius muscle will be included in this study.
* Participants have chronic myofascial trigger points if they have pain with pressure, local twitch response, jump sign, limited range of motion and referred pain lies over the lateral aspect of the upper trapezius fibers and superiorly to the ipsilateral occiput.
* Normal body mass index (BMI) from 18-24.9 Kg/m (BMI = body mass in kg divided by participant height in meters).

Exclusion Criteria

* Onset of pain less than 3 months
* History of whiplash injury
* History of cervical spine surgery
* Cervical radiculopathy or myelopathy and cervical disc lesion
* Cervical spondylolisthesis
* Having multiple sclerosis, thyroid dysfunction and chronic infection
* Having rheumatologic condition as poly articular osteoarthritis, rheumatoid arthritis and advanced cervical spine degenerative diseases
* Skin disease and impaired sensation
* Phobia of using electrical current
* Pregnancy, tumor, thrombosis and pacemaker
* Administration of regular analgesic drugs or any medications that affect skin sensation.
* Receiving physical therapy intervention during the past three months.
Minimum Eligible Age

18 Years

Maximum Eligible Age

29 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alaa Samir Elsaid Mohamed

Assistant Lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Physical Therapy Cairo University

Giza, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

References

Explore related publications, articles, or registry entries linked to this study.

Venancio RC, Pelegrini S, Gomes DQ, Nakano EY, Liebano RE. Effects of carrier frequency of interferential current on pressure pain threshold and sensory comfort in humans. Arch Phys Med Rehabil. 2013 Jan;94(1):95-102. doi: 10.1016/j.apmr.2012.08.204. Epub 2012 Aug 23.

Reference Type BACKGROUND
PMID: 22922327 (View on PubMed)

Correa JB, Costa LO, Oliveira NT, Lima WP, Sluka KA, Liebano RE. Effects of the carrier frequency of interferential current on pain modulation and central hypersensitivity in people with chronic nonspecific low back pain: A randomized placebo-controlled trial. Eur J Pain. 2016 Nov;20(10):1653-1666. doi: 10.1002/ejp.889. Epub 2016 May 6.

Reference Type BACKGROUND
PMID: 27150263 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P.T.REC/012/003591

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.